Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
45
Number of overlapping holdings
33.1%
% of XBI's 136 holdings also in BBP
73.8%
% of BBP's 65 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.5% | 2.1% | 2.1% |
|
INSMED INC | 2.6% | 1.8% | 1.8% |
|
GILEAD SCIENCES INC | 3.0% | 1.8% | 1.8% |
|
TG THERAPEUTICS INC | 1.7% | 1.8% | 1.7% |
|
UNITED THERAPEUTICS CORP | 2.9% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BBP
|
NATERA INC | 3.5% |
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
EXACT SCIENCES CORP | 2.5% |
|
ABBVIE INC | 2.4% |
|
VIKING THERAPEUTICS, INC. | 1.9% |
|
CYTOKINETICS INC | 1.6% |
|
INCYTE CORP | 1.3% |
 |
ALKERMES PLC | 1.2% |
|
NEUROCRINE BIOSCIENCES INC | 1.2% |
|
REVOLUTION MEDICINES, INC. | 1.2% |
XBI Underweight Relative to BBP
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% |
|
MIRUM PHARMACEUTICALS, INC. | -1.8% |
 |
THERAVANCE BIOPHARMA INC | -1.8% |
|
TRAVERE THERAPEUTICS, INC. | -1.7% |
|
AXSOME THERAPEUTICS, INC. | -1.7% |
|
INTRA-CELLULAR THERAPIES INC | -1.7% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |
|
PHATHOM PHARMACEUTICALS, INC. | -1.6% |